Replies to post #70593 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

One of the characteristics which makes CiaB technology unique is the ability to be cryopreserved for years and then thawed with up to 95% viability, which of course lends itself the ability to be shipped anywhere in the world. CiaB is also completely bioinert and can be safely inside the human body for up to two years or longer. The IND is being drafted as we speak, the master cell bank is currently being produced and we will soon be ready to submit the IND and begin the clinical trial. I'm thinking the trial begins this October or November which puts the 6-month hard stop somewhere around April '18 - May '18.

[frosr6]

The FDA will be the judge of if its CGMP. Until then it can be called whatever one wants to call it to help in unloading shares.

Quote:
"Austrianova have now solved the cGMP of cell production required for this delivery method which has given it a new life."